From: Subgroup identification for treatment selection in biomarker adaptive design
 | DLDA | ASD (−0.5,1) | ASD (−0.5,2) | ASD (−1,1) | ASD (−1,2) |
---|---|---|---|---|---|
Comparison 1 | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 |
Comparison 4 | 0.018 | 0.049 | 0.014 | NA | NA |
Comparison 5 | 0.86 | 0.024 | NA | NA | NA |
Comparison 2 | 0.578 | 0.739 | NA | NA | NA |
Comparison 3 | 0.432 | 0.061 | 0.024 | 0.014 | 0.014 |
g+ (T) | 3.40 (55)a | 2.95 (118) | 2.80 (146) | 1.84 (152) | 1.84 (152) |
g+ (C) | 2.36 (97) | 1.98 (34) | 1.16 (6) | NA (0) | NA (0) |
g− (T) | 3.82 (73) | 3.89 (75) | 3.46 (80) | 3.46 (80) | 3.46 (80) |
g− (C) | 3.35 (7) | 2.02 (5) | NA (0) | NA (0) | NA (0) |